Bloomberg News

Hologic Says Cumming to Return as CEO as Cascella Resigns Post

July 18, 2013

Hologic Inc. (HOLX:US), a maker of cervical cancer and breast biopsy tools, said Chief Executive Officer Robert Cascella quit for personal reasons and will be replaced by former Chairman and CEO Jack Cumming.

Cumming served as CEO from 2001 to 2009, and was chairman from 2002 through 2007 and again from 2008 to 2011, according to a statement today from the Bedford, Massachusetts-based company.

Hologic also said it expects to report third-quarter adjusted earnings of 38 cents a share, which would be 1 cent more than the average of 19 analysts’ estimates (HOLX:US) compiled by Bloomberg. The company plans to release full results on Aug. 5.

Hologic shares rose 5.1 percent to $21 at 5:02 p.m. in New York. It gained 2.5 percent to close at $19.97 in regular trading. The stock has fallen (HOLX:US) less than 1 percent this year.

To contact the reporter on this story: Elizabeth Lopatto in San Francisco at elopatto@bloomberg.net

To contact the editor responsible for this story: Reg Gale at rgale5@bloomberg.net


The Good Business Issue
LIMITED-TIME OFFER SUBSCRIBE NOW

Companies Mentioned

  • HOLX
    (Hologic Inc)
    • $26.89 USD
    • 0.10
    • 0.37%
Market data is delayed at least 15 minutes.
 
blog comments powered by Disqus